导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.34% | 277/1050 |
| 近一周 | -1.51% | 224/1104 |
| 近一月 | -2.97% | 344/1102 |
| 近一季 | 24.78% | 20/1092 |
| 近半年 | 11.34% | 232/1070 |
| 近一年 | -8.83% | 723/1018 |
| 近两年 | 39.09% | 598/926 |
| 近三年 | 17.29% | 523/834 |
| 成立以来 | 5.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.48% 228/1070 |
-5.10% 799/1101 |
- - |
- - |
| 2025 | 20.82% 652/1065 |
9.58% 158/1014 |
9.27% 124/1038 |
23.24% 503/1050 |
-18.12% 1026/1065 |
| 2024 | -12.13% 807/1011 |
-7.63% 676/960 |
-2.90% 501/983 |
8.97% 715/991 |
-10.09% 900/1011 |
| 2023 | -8.04% 277/952 |
1.01% 577/880 |
-3.46% 416/895 |
-2.92% 199/915 |
-2.86% 317/952 |
| 2022 | -20.27% 332/867 |
-17.62% 399/773 |
2.38% 654/806 |
-14.47% 535/845 |
10.53% 71/867 |
| 2021 | -7.10% 451/740 |
-6.17% 388/580 |
24.05% 101/659 |
-15.33% 617/704 |
-5.75% 610/740 |
| 2020 | 46.06% 262/554 |
3.56% 88/419 |
30.39% 125/466 |
3.38% 382/517 |
4.63% 443/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华商医药医疗行业股票 VS. 东吴新产业精选股票A(580008) |